Can closing a heart hole stop strokes in seniors? new trial aims to find out

NCT ID NCT05907694

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether closing a small hole in the heart (called a PFO) plus medication is better than medication alone at preventing repeat strokes in people over 60 who have had a cryptogenic stroke (a stroke with no clear cause). About 714 participants will be randomly assigned to either get the closure procedure or just medical treatment. The goal is to see if the procedure reduces the risk of another stroke in this older population, who have been left out of most previous studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Transcatheter PFO closure procedure plus antithrombotic medication

What this could lead to

If successful, this could provide an effective way to prevent recurrent strokes in older adults with a PFO, expanding treatment options beyond medication alone.

What could go wrong

This is an early-stage trial with no phase designation, and results may not confirm benefit. The procedure carries risks like bleeding, new atrial fibrillation, or device complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

patent foramen ovale stroke disorder ischemic stroke prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IUCPQ

    RECRUITING

    Québec, Quebec, G2E4G9, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • IUCPQ-UL

    ACTIVE_NOT_RECRUITING

    Québec, Quebec, G1V 4G5, Canada